Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Universal Ibogaine Inc ( (TSE:IBO) ) has issued an update.
Universal Ibogaine Inc. has applied for a Management Cease Trade Order (MCTO) due to its inability to file its audited financial statements by the deadline, caused by limited financial resources. The company is undergoing restructuring and refinancing efforts to address this issue and expects to complete the filings by January 30, 2026. Despite the MCTO application, public trading of the company’s shares will continue, and the company will provide bi-weekly updates until the filings are completed.
More about Universal Ibogaine Inc
Universal Ibogaine Inc. is a life sciences company focused on transforming addiction treatment through medicalized ibogaine. The company plans to conduct a Canadian clinical trial targeting opioid use disorder and aims to expand its treatment protocol globally through future licensing agreements.
Average Trading Volume: 278,211
Technical Sentiment Signal: Sell
Current Market Cap: C$1.37M
Find detailed analytics on IBO stock on TipRanks’ Stock Analysis page.